Tetsuya Takimoto
Overview
Explore the profile of Tetsuya Takimoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
687
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Fukano R, Iijima-Yamashita Y, Iwafuchi H, Nakazawa A, Saito A, Takimoto T, et al.
Haematologica
. 2023 Sep;
109(2):652-656.
PMID: 37675509
No abstract available.
12.
Nakamura Y, Mizukami H, Tanese K, Fusumae T, Hirai I, Amagai M, et al.
J Dermatol Sci
. 2023 Sep;
112(1):23-30.
PMID: 37661472
Background: Extramammary Paget's disease (EMPD) is a rare intraepithelial adenocarcinoma that mainly affects the anogenital and axillary regions. Although its etiology has not been fully elucidated, there is evidence that...
13.
Kaneko K, Tsutsumi S, Fujita D, Sugiura-Ogasawara M, Mitsuda N, Matsubara K, et al.
Mod Rheumatol
. 2023 Jun;
34(3):515-522.
PMID: 37340865
Objectives: The objective of the study was to compare the efficacy of intravenous immunoglobulin (IVIG) therapy for obstetric antiphospholipid syndrome (APS) refractory to conventional treatment. Methods: We conducted a single-arm,...
14.
Shima H, Sato S, Takimoto T, Sakai M, Hashida N, Isshiki K, et al.
Pediatr Int
. 2023 Feb;
65(1):e15487.
PMID: 36799122
No abstract available.
15.
Sakamoto K, Kikuchi K, Sako M, Kato M, Takimoto T, Shioda Y
Medicine (Baltimore)
. 2022 Dec;
101(50):e31475.
PMID: 36550910
This study was a non-blinded, multicenter, single-arm study. Recurrent (relapsed) LCH is defined as the appearance of new lesions or the enlargement of preexisting lesions due to LCH. In this...
16.
Miyazaki O, Oguma E, Nishikawa M, Tanami Y, Hosokawa T, Kitami M, et al.
Pediatr Radiol
. 2022 Oct;
53(3):367-377.
PMID: 36255457
Background: No previous research papers have reported a comparative survey of local radiologic diagnoses and central review in children with hepatoblastoma. Objective: To evaluate the utility of central review of...
17.
Takahashi S, Sato S, Igarashi S, Dairoku H, Takiguchi Y, Takimoto T
BMC Pediatr
. 2022 May;
22(1):298.
PMID: 35597905
Background: Although treatment of acute myeloid leukemia (AML) contains neurotoxic agents, studies investigating neurocognitive outcomes in children with AML are sparse. We evaluated late cognitive effects in children treated with...
18.
Hishiki T, Honda S, Takama Y, Inomata Y, Okajima H, Hoshino K, et al.
Children (Basel)
. 2022 Feb;
9(2).
PMID: 35204954
In the JPLT3 study, a real-time central surgical reviewing (CSR) system was employed aimed at facilitating early referral of candidates for liver transplantation (LTx) to centers with pediatric LTx services....
19.
Hara J, Nitani C, Shichino H, Kuroda T, Hishiki T, Soejima T, et al.
Jpn J Clin Oncol
. 2022 Feb;
52(5):486-492.
PMID: 35137156
Background: In Japan, allogeneic hematopoietic stem cell transplantation is widely performed for recurrent neuroblastomas. This retrospective study aimed to investigate the prognosis of recurrent neuroblastoma in Japan and explore the...
20.
Ohira M, Nakamura Y, Takimoto T, Nakazawa A, Hishiki T, Matsumoto K, et al.
Biomolecules
. 2022 Jan;
12(1).
PMID: 35053166
Neuroblastomas (NBs) exhibit broad and divergent clinical behaviors and tumor risk classification at diagnosis is crucial for the selection of an appropriate therapeutic strategy for each patient. The present study...